SwALife Antioxidant Network Pharmacology Predictor: Designing the Future of Nutraceuticals with AI-Driven Antioxidant Modeling

Abstract

The increasing demand for evidence-based nutraceuticals has driven the integration of artificial intelligence and systems biology into antioxidant research. The SwALife Antioxidant Network Pharmacology Predictor represents an innovative AI-driven platform designed to model, predict, and optimize antioxidant activity through a network pharmacology framework. By integrating bioactive compound databases, molecular interaction networks, and predictive computational algorithms, SwALife enables comprehensive mapping of antioxidant–target–pathway relationships at a systems level. This approach facilitates the identification of multi-target mechanisms, synergistic interactions, and key signaling pathways involved in oxidative stress modulation. The platform supports rational nutraceutical design by providing in silico validation of antioxidant efficacy, safety, and functional relevance prior to experimental or clinical evaluation. Furthermore, SwALife enhances translational potential by bridging traditional nutraceutical knowledge with modern computational intelligence, enabling personalized and precision-oriented antioxidant interventions. Overall, the SwALife Antioxidant Network Pharmacology Predictor exemplifies a next-generation framework for nutraceutical innovation, accelerating discovery pipelines while improving scientific rigor, cost-efficiency, and predictive reliability in antioxidant modeling.